HomeTeva Pharm expects to start paying U.S. opioid settlement in 2023FILE PHOTO: The CEO of Teva Pharmaceutical Industries Kare Schultz

FILE PHOTO: The CEO of Teva Pharmaceutical Industries Kare Schultz

FILE PHOTO: The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File Photo
- Advertisment -
Google search engine

Most Read